Clinical Trial Update: Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates the durability of the immune response to Hepatitis B vaccination in children aged 7-9 years who were previously vaccinated with a D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED